Skip to content

Western Australia Asbestos Review Program

Western Australia Asbestos Review Program: medical follow up of West Australians exposed to asbestos

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12621001627842
Acronym
ARP
Enrollment
5002
Registered
2021-11-29
Start date
1990-02-01
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is a longitudinal observational study that will monitor the health of Western Australians who have been exposed to asbestos through an annual clinical review. Who is it for? You may be eligible for this study if you are a resident of Western Australia aged 16 years or older, you are an asbestos exposed ex-worker and/or ex-resident of Wittenoom (the asbestos mine), or if you are an individual with more than 3 months cumulative asbestos exposure and/or radiological evidence of asbestos related disease. Study details All participants who choose to enrol in this study will be asked to undergo a general and lung health assessment, lung function tests and an ultra-low dose CT scan of the chest to look for lung disease from asbestos. The Western Australian Asbestos Review Program (ARP) also performs blood tests to see if we can find markers of lung disease to help diagnose problems earlier. Each of these investigations will be completed annually, the appointment usually takes about two hours. The ARP has no limit on age or how long it is since first exposure to asbestos – the study aims to follow as many people exposed to asbestos for as long as possible. It is hoped this research will provide important information that will allow clinicians to further characterise, diagnose and understand asbestos-related diseases. This information may then be used to improve health outcomes of future patients who have been affected by asbestos exposure.

Interventions

A two hour annual review at of persons exposed to asbestos during work or otherwise including general health and specific respiratory questionnaire, blood draw for biomarkers and DNA and lung function followed by ultra-low dose computed tomography (CT) imaging of the chest. Anticipated duration of follow annual up is up to 30 years although participants may choose to continue after this time. Annual reviews and prospective data collection have occured since 1990. There is no retrospective data

A two hour annual review at of persons exposed to asbestos during work or otherwise including general health and specific respiratory questionnaire, blood draw for biomarkers and DNA and lung function followed by ultra-low dose computed tomography (CT) imaging of the chest. Anticipated duration of follow annual up is up to 30 years although participants may choose to continue after this time. Annual reviews and prospective data collection have occured since 1990. There is no retrospective data collection.

Sponsors

Sir Charles Gairdner Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Women and men who fulfil one or more criteria: • Minimum of 3 months cumulative exposure to asbestos • Any Wittenoom resident/worker and/or • Evidence of asbestos related disease on radiological imaging

Exclusion criteria

• <16 years of age • Unstable or untreated medical condition that requires intervention or management • Unable to attend annual appointments or comply with the study requirements

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 30, 2026